GLP-1s: The Medications Redefining Diabetes and Obesity Treatment
MedPage Today December 4, 2024
— Experts tackle access, equity, and the blockbuster drugs reshaping healthcare
In part one of this three-part Instagram Live discussion, MedPage Today editor-in-chief Jeremy Faust, MD, talks about how GLP-1 receptor agonists are transforming diabetes and obesity care in a discussion with Karl Nadolsky, DO, a clinical endocrinologist and obesity specialist at Holland Hospital in Michigan, and Fatima Cody Stanford, MD, MPH, an associate professor of medicine and pediatrics at Massachusetts General Hospital and Harvard Medical School in Boston.
Following is a partial transcript of the video (note that errors are possible):
Faust: I just want to start, first of all, by thanking the two of you because, I think, maybe 2 years ago when we first did this session,...